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Spinal cord injury often results in permanent functional impairment. Neural stem cells present in the adult spinal cord
can be expanded in vitro and improve recovery when transplanted to the injured spinal cord, demonstrating the
presence of cells that can promote regeneration but that normally fail to do so efficiently. Using genetic fate mapping,
we show that close to all in vitro neural stem cell potential in the adult spinal cord resides within the population of
ependymal cells lining the central canal. These cells are recruited by spinal cord injury and produce not only scar-
forming glial cells, but also, to a lesser degree, oligodendrocytes. Modulating the fate of ependymal progeny after
spinal cord injury may offer an alternative to cell transplantation for cell replacement therapies in spinal cord injury.
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Introduction
Transplantation of different types of stem cells improves
functional recovery after spinal cord injury in rodents and
primates. The beneﬁcial effects appear to be mediated by
several mechanisms, including replacement of lost cells,
secretion of neurotrophic factors, and probably most
importantly, the generation of oligodendrocytes that remye-
linate spared axons in the vicinity of a lesion [1,2].
Neural stem cells present in the adult spinal cord can be
propagated in vitro [3,4], and promote functional recovery
when transplanted to the injured spinal cord [5]. Endogenous
neural stem cells could therefore be attractive candidates to
manipulate for the production of desired progeny after
spinal cord injury as an alternative to stem cell trans-
plantation. This approach would offer a noninvasive strategy
that avoids the need for immune suppression, but has been
held back by difﬁculties in identifying adult spinal cord
neural stem cells and developing rational ways to modulate
their response to injury. Studies using indirect techniques
have suggested that the neural stem cell potential in the adult
rodent spinal cord resides in the white matter parenchyma
[6,7] or close to the central canal, either in the ependymal
layer [8] or subependymally [9].
We have employed genetic fate mapping to characterize a
candidate neural stem cell population in the adult spinal cord
and show that close to all in vitro neural stem cell potential
resides within the population of ependymal cells. Ependymal
cells give rise to a substantial proportion of scar-forming
astrocytesas well as to some myelinating oligodendrocytesafter
spinal cord injury. Modulating the fate of ependymal cell
progeny after injury could potentially promote the generation
ofcelltypesthat may facilitate recovery afterspinalcordinjury.
Results
Genetic Labeling of Cells in the Adult Spinal Cord
Ependymal Layer
In order to fate map candidate neural stem cells close to
the central canal, we generated two transgenic mouse lines
expressing tamoxifen-dependent Cre recombinase (CreER)
under the control of FoxJ1 (HFH4) or Nestin regulatory
sequences. FoxJ1 expression is speciﬁc to cells possessing
motile cilia or ﬂagella [10–13]. In the adult forebrain, a subset
of astrocytes in the subventricular zone contact the ventricle
and have an immotile primary cilium [14], but FoxJ1
expression is restricted to cells with motile cilia [10–13].
Nestin is expressed in central nervous system stem and
progenitor cells during development and in adulthood [15–
19]. In the adult spinal cord, nestin is expressed by cells lining
the central canal, endothelial cells, and sparse white matter
glial cells [20]. The second intron enhancer in the Nestin gene
allows for selective expression of CreER in the neural lineage
[21], eliminating expression in for example endothelial cells.
CreER expression in the adult spinal cord is limited to cells
lining the central canal in both the FoxJ1-CreER and Nestin-
CreER mouse lines (Figure 1). Administration of tamoxifen to
mice on an R26R [22] or Z/EG [23] Cre reporter background
allows inducible, permanent. and heritable genetic labeling
by the expression of b-galactosidase (b-gal; R26R) or GFP (Z/
EG) in cells expressing CreER (the strategy is schematically
depicted in Figure S1). Recombination in the absence of
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PLoS BIOLOGYtamoxifen was exceptionally rare (,1 cell/30 coronal 20-lm-
thick sections in both transgenic lines) and limited to CreER-
expressing cells in the ependymal layer. Administration of
tamoxifen (ﬁve daily injections) resulted in recombination of
the reporter allele (Figure 1A–1D) in 82 6 4% of transgene-
expressing cells in Nestin-CreER mice and 88 6 4% in FoxJ1-
CreER mice (mean 6 standard deviation [SD], n ¼ 6 mice for
each mouse line).
Phenotypic Characterization of Adult Spinal Cord
Ependymal Cells
The cells at the central canal expressing CreER protein
from the Nestin-CreER or FoxJ1-CreER transgene are immu-
noreactive to Crocc, a marker for ciliated cells (Figure S2).
They contain the intermediate ﬁlaments nestin and vimentin,
associated with immature neural cells [15], but notably not
glial ﬁbrillary acidic protein (GFAP) (Figures S2 and S3),
which is present in some neural stem cells in the adult
forebrain [24]. The transgene expressing cells display other
markers associated with neural stem/progenitor cells such as
CD133/prominin-1, Musashi1, PDGFR-a, Sox2, Sox3, and
Figure 1. Genetic Labeling of Spinal Cord Ependymal Cells
Transgenic mice with tamoxifen-inducible Cre recombinase (CreER) under the control of the FoxJ1 promoter (A and B) or the Nestin second intron
enhancer (C and D) drive expression and induce recombination after 5 daily tamoxifen injections (resulting in b-gal expression) in cells lining the central
canal in the adult spinal cord.
(A and C) Overviews of coronal sections from the thoracic spinal cord and (B and D) higher magnification of the central canal region demonstrating
recombination in the majority of cells and cytoplasmic CreER protein 6 days after the last tamoxifen administration. Cell nuclei are visualized with DAPI
in (A and C). Scale bars indicate 100 lm in (A) and (C), and 25 lm in (B) and (D).
doi:10.1371/journal.pbio.0060182.g001
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Author Summary
Spinal cord injuries occur in more than 30.000 individuals each year
worldwide and result in significant morbidity, with patients
requiring long physical and medical care. The recent identification
of resident stem cells in the adult spinal cord has opened up for the
possibility of pharmacological manipulation of these cells to
produce cell types promoting recovery after injury. We have
employed genetic tools to specifically address the identity and
reaction to injury of a spinal cord subpopulation of cells known as
ependymal cell. Genetic labeling of this putative stem cell
population allows for the evaluation of stem cell activity in vitro
and in vivo. We found that ependymal cells lining the central canal
act as neural stem cells in vitro and contribute extensively to the
glial scar in vivo. Interestingly, injury induces proliferation of
ependymal cells and migration of ependyma-derived progeny
towards the site of injury. Moreover, ependymal cell progeny
differentiate and give rise to astrocytes as well as myelinating
oligodendrocytes. In summary, our results point to ependymal cells
as an attractive candidate population for non-invasive manipulation
after injury.Sox9 but are negative for the oligodendroglial progenitor
marker Olig2 (Figures S2 and S3). All above-mentioned
proteins appear uniformly expressed by the cells lining the
central canal, and we have not found any molecular marker
delineating any subpopulations.
Immunoelectron microscopy established that the Nestin-
CreER and FoxJ1-CreER transgenes are expressed in identical
cell populations by the central canal; their expression is
restricted to lumen-contacting cells with motile cilia (9 þ 2
axonemes), and all such cells express both transgenes (Figures
2A–2C, S4, and S5). Ultrastructural analysis in serial sections
revealed morphological heterogeneity among the lumen-
contacting ciliated cells, with some cells displaying typical
cuboidal ependymal cell morphology and others a tanycyte
morphology [25] (Figures 2C, 2D, S4, and S5). In addition,
there is a less numerous third cell type, which we refer to as a
radial ependymal cell. Radial ependymal cells share the
morphology of the cytoplasm, and often nucleus, with
ependymal cells, but have a long basal process (Figures 2B,
2D, and S5). The radial ependymal cells almost invariably
reside in the dorsal or ventral pole of the ependymal layer,
with a basal process oriented along the dorsoventral axis
(Figures 2A and S5). Although the lumen-contacting ciliated
cells can be subdivided into these three groups, cells with
intermediary phenotypes are frequent (Figure 2E and Table
S1), which together with their homogeneous molecular
proﬁle suggests that they are closely related. The naming of
ependymal cell types is based solely on morphological criteria
and does not imply any function. The central canal-
contacting ciliated cells have in common that they reside in
the ependymal layer, thus we collectively refer to them as
ependymal cells.
Adult Spinal Cord Stem Cells Are Largely Contained within
the Ependymal Cell Population
Adult spinal cord neural stem cells can be propagated in
vitro [3], but their precise identity has been difﬁcult to
establish unequivocally [6–9]. We utilized our genetic labeling
paradigms to ask whether adult spinal cord ependymal cells
have neural stem cell properties in vitro. Adult FoxJ1-CreER
and Nestin-CreER mice on Cre recombination reporter back-
ground (R26R or Z/EG) received ﬁve daily injections of
tamoxifen to induce recombination, and primary cultures
were initiated after an additional 6 d without tamoxifen
(Figure 3A). Tamoxifen and its active metabolite 4-hydrox-
ytamoxifen have a half-life of 6–12 h in the mouse [26], and
accordingly CreER protein was no longer detectable in the
nucleus after 6 d without tamoxifen (Figure 1B and 1D).
Spinal cords were dissociated and plated at clonal density in
standard conditions that allow for neurosphere formation
(Figure 3B). We found that 76 6 5.7% of neurospheres from
Nestin-CreER and 85 6 2.2% from FoxJ1-CreER mice were
recombined and thus derived from recombined ependymal
cells (mean 6 SD, n ¼ 6 mice analyzed separately per line,
Figure 2. Characterization of Spinal Cord Ependymal Cells
(A–C) Immunoelectron microscopy of the central canal in a FoxJ1-CreER mouse. Pseudocoloring in (A) illustrates the localization of CreER-
immunoreactive radial ependymal cells (B), cuboidal ependymal cells, and tanycytes (C).
(D) Table with color code for (A–C), describing the characteristics of the three cell types that line the central canal.
(E) Venn diagram illustrating the percentage of cuboidal ependymal cells, tanycytes, radial ependymal cells, and intermediate morphologies (see
Figures S4 and S5, and Table S1 for details on the ultrastructural analysis). Scale bars indicate 10 lm in (A) and 3 lm in (B) and (C).
doi:10.1371/journal.pbio.0060182.g002
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Spinal Cord Neural Stem CellsFigure 3C and 3E). Neurospheres were either homogeneously
recombined or not recombined, verifying their clonal origin.
Since recombination never was fully penetrant in the
ependymal cells, the analysis of the proportion of neuro-
spheres that were recombined may underestimate the true
contribution of this cell population to neurosphere forma-
tion. If there is a stochastic distribution of recombination
within the CreER expressing cell population, rather than
recombination demarcating a subpopulation that differs with
regard to neurosphere-forming potential, one can estimate
the contribution of the cell population to neurosphere
formation by normalizing it to the observed recombination
rate. To estimate the theoretically maximal proportion of
neurosphere-initiating cells that are ependymal cells, we
Figure 3. Ependymal Cells Display Neural Stem Cell Properties In Vitro
(A) Schematic depiction of tamoxifen administration paradigm and (B) analysis of neural stem cell properties and in vivo and in vitro recombination
frequency.
(C) The high proportion of recombined (rec.) neurospheres (mean þ SD, n ¼ 6 mice for each transgenic mouse line) demonstrates that the majority
derives from ependymal cells.
(D) Estimate of the proportion of neurospheres that derive from ependymal cells by normalization to the recombination rate in tissue sections of the
spinal cords that were used to initiate the cultures (mean 6 SD).
(E) Recombined primary neurospheres from FoxJ1-CreER mice on R26R background visualized by X-gal staining (arrow points to one unrecombined
neurosphere).
(F) Differentiation of a clonally derived recombined neurosphere into neurons (bIIItub), astrocytes (GFAP), and oligodendrocytes (O4).
(G) Flow cytometric isolation of GFP
þ cells from the spinal cord of adult FoxJ1-CreER mice based on the IRES-GFP signal (GFP gate). 7-AAD labels dead
cells, which were excluded.
(H–K) Brightfield (BF) and fluorescent images (I and K) of a single GFP
þ sorted cell and a neurosphere (J) formed from such a cell, which is GFP
  due to
the lack of FoxJ1 expression (K).
Scale bars indicate 400 lm in (E), 20 lm in (F), 100 lm in (H) and (I), and 50 lm in (J) and (K).
doi:10.1371/journal.pbio.0060182.g003
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Spinal Cord Neural Stem Cellsanalyzed the recombination frequency in CreER-expressing
cells in sections from each spinal cord sample that was used
for neurosphere cultures (Figure 3B). Normalizing the
recombination frequency in neurospheres to the recombina-
tion frequency in the CreER-expressing cells in vivo,
suggested that close to all neurosphere-initiating potential
could reside within the ependymal cell population under
these conditions (Figure 3D).
Progenitor cells with limited self-renewal capacity can give
rise to neurospheres, but are incapable of generating new
neurospheres when passaged more than twice [27,28]. We
found that 100% of the recombined neurospheres from both
Nestin-CreER and FoxJ1-CreER could be serially passaged at
least eight times to give rise to new neurospheres (n ¼ 6
neurospheres per 4 transgenic mice). The number of cells
increased exponentially during passaging (Figure S6). Anal-
ysis of the differentiation potential of ependymal cell-derived
neurospheres after three passages revealed that 100% of the
neurosphere clones were multipotent and differentiated into
neurons, astrocytes, and oligodendrocytes (Figure 3F).
We also isolated prospectively identiﬁed ependymal cells by
ﬂow cytometry independently of Cre-mediated recombina-
tion by utilizing the green ﬂuorescent protein (GFP)
expression under the bicistronic control of the FoxJ1
promoter (Figures 3G and S1). Flow cytometric isolation of
adult spinal cord cells substantially reduced neurosphere
formation, and 0.18 6 0.06% (mean 6 SD from in average
1,600 GFP-positive (GFP
þ) cells/mouse, n ¼ 6 mice analyzed
separately) of GFP
þ ependymal cells formed neurospheres
(Figure 3H–3K). In contrast, not a single neurosphere
developed from the same number of cells in the GFP
  non-
ependymal fraction from any animal in the same experi-
ments. Thus, the neural stem cell potential in the adult spinal
cord, at least under the conditions employed here, largely
resides within the ependymal cell population.
Ependymal Cells Self-Renew In Vivo
Cells in the adult spinal cord ependymal layer proliferate,
albeit slowly or rarely [8]. Continuous administration for one
month in the drinking water of 5-bromo-2-deoxyuridine
(BrdU), which is incorporated into DNA in cells in S-phase,
resulted in labeling of 19.9 6 4.2% of ependymal cells (mean
6 SD from three mice, Figure 4A and 4B). The BrdU-labeled
ependymal cells constituted 4.8 6 0.9% of all BrdU-labeled
cells in a spinal cord segment (mean 6 SD from three mice).
The majority of BrdU-labeled ependymal cells were found in
pairs, indicating that most mitoses resulted in self-duplica-
tion rather than the generation of another cell that had left
the ependymal layer (Figure 4A and 4B). In line with this,
analysis of the distribution of recombined cells up to 8 mo
after tamoxifen administration in the FoxJ1-CreER and Nestin-
CreER mice did not provide evidence for the generation of
cells that leave the ependymal layer under normal conditions
(unpublished data).
Whether a speciﬁc cell population is derived from another
cell type or it is maintained through self-duplication can be
established by analyzing the genetic labeling frequency at
different time points after induction of recombination
[29,30]. There was no reduction in the proportion of
recombined ependymal cells for up to 10 mo after tamoxifen
administration (Figure 4C–4E), indicating that ependymal
cells are maintained by self-renewal and are not replenished
by another cell population.
Ependymal Cells Are Activated by Spinal Cord Injury
We next assessed the response of ependymal cells to spinal
cord injury. We used the same labeling paradigm as before
(Figure 3A), with a 6-d period between the last tamoxifen
dose and the injury. This ensures that all recombination
occurs prior to the insult and that even if other cells than
ependymal cells would start to express the FoxJ1-CreER or
Nestin-CreER transgene in response to the injury (nestin is
indeed expressed by reactive astrocytes [20]), it would not
result in recombination. An incision in the dorsal funiculus,
which does not compromise the integrity of the ependymal
layer, dramatically increased the proliferation of ependymal
cells (Figures 5A, 5B, and S7). In contrast to the uninjured
spinal cord, where proliferation of ependymal cells appears
largely limited to self-renewing divisions, recombined cells
started to migrate and were located outside the ependymal
layer 4 d after the injury (Figure 5C–5I). Migrating recom-
bined cells lost their ependymal phenotype as judged by the
loss of immunoreactivity to Sox2 and Sox3 and lack of CreER
expression from the FoxJ1 promoter (Figure 3D and unpub-
lished data). Most emigrating cells expressed Sox9 and some
the astrocyte marker GFAP (Figure 5F, 5H, and 5I). Ultra-
structural analysis revealed that ependymal cell morphology
was largely unaltered by the injury, with the exception of a
darker cytoplasm due to a higher content of ﬁlaments (Figure
5J and 5K).
Figure 4. Ependymal Cells Self-Renew In Vivo
(A and B) BrdU incorporation in ependymal cells after 4-wk admin-
istration in the drinking water. Many of the labeled cells are found in
pairs (arrowheads).
(A) shows a coronal and (B) a sagittal section.
(C–E) The recombination (rec.) rate of ependymal cells remains at the
same level from 2 d to 10 mo after tamoxifen administration (mean and
SD from 3–4 mice at each time point).
The scale bar indicates 25 lm in (A–D).
doi:10.1371/journal.pbio.0060182.g004
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Spinal Cord Neural Stem CellsEpendymal Cells Contribute to Scar Formation after Injury
Ependymal progeny migrated towards the injury site in the
dorsal funiculus and an increasing number of recombined
cells accumulated in the forming glial scar over several weeks
and remained there for at least 10 mo after the insult (Figure
6A–6C). The recombined ependyma-derived cells occupied
18.3 6 6.9% (mean 6 SD from three FoxJ1-CreER mice) of the
area in the scar tissue 2 wk after the injury, which is likely to
be a slight underestimate of the true contribution since
recombination never was fully penetrant. The ependyma-
derived cells were not evenly distributed throughout the
injury site, but the scar consisted of patches of recombined
and unrecombined cells (Figure 6H and 6I). The reaction of
the ependymal cells was restricted to the injured segment and
was absent in adjacent segments (Figures 5A–5H and 6A–6C),
which are indirectly affected by the severance of axons and
Wallerian degeneration. There were no recombined cells
outside the ependymal layer in animals in which only the
spinal cord was exposed but no lesion was made (sham lesion,
Figure S8), and a lesion did not induce recombination in
animals that had not received tamoxifen (unpublished data).
Since some ependymal cells extend processes along the
dorsolateral midline, it was possible that the activation of
ependymal cells by a dorsal funiculus incision was triggered
by the severance of such processes. To investigate this, we
performed incisions in the lateral spinal cord, which do not
directly injure the ependymal cell processes in the dorso-
lateral midline. In these animals, ependymal cell progeny
were generated and migrated laterally towards the injury
(Figure S8). The ependyma-derived cells migrating to the
lesion appeared less numerous after a lateral than after a
dorsal incision, suggesting that severance of ependymal cell
processes in the midline is not necessary for the activation of
ependymal cells, but that it may augment their reaction. The
migration of ependyma-derived cells to the site of injury
suggests the presence of attractive signals originating in the
lesion area. SDF1, through its receptor CXCR4, mediates
attraction of progeny from neural stem/progenitor cells after
some types of injuries [31,32]. The majority of ependymal
Figure 5. Ependymal Cells Are Activated by Injury
Uninjured and adjacent injured segments from mice 4 d after a dorsal funiculus incision. Recombined cells leave the ependymal layer in the injured
segments (arrowheads). (A and B) Ki67 immunoreactivity indicates ependymal proliferation in the injured, but not in the uninjured segment. Migrating
recombined cells lose Sox3 expression (D), but most are Sox9 immunoreactive, and a smaller population is GFAP immunoreactive (F–I). Some
ependymal cells within the ependymal layer (outlined by hatched line in [I]) become GFAP immunoreactive (arrows). (J and K) Electron micrographs of
an extended ependymal cell with a dense filamentous matrix (f) in the cytoplasm 4 wk after injury in a FoxJ1-CreER mouse. n, nucleus.
Scale bars indicate 25 lm in (A–H), 10 lm in (I), 1.5 lm in (J), and 0.2 lm in (K).
doi:10.1371/journal.pbio.0060182.g005
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Spinal Cord Neural Stem CellsFigure 6. Ependymal Cells Contribute to Scar Formation after Spinal Cord Injury
(A) Distribution of b-gal–immunoreactive ependyma-derived cells in coronal sections from an uninjured segment (left) further towards the lesion
epicenter (right).
(B and C) Sagittal sections show the distribution of recombined cells 1 mo (B) and 10 mo (C) after a dorsal funiculus incision (indicated by hatched lines).
(D and E) Recombined cells outside the ependymal layer display either (D) the astrocytic marker GFAP or (E) a Sox9/vimentin double-positive profile.
(F and G) Other recombined cells are Olig2 immunoreactive (arrowheads) and have oligodendrocyte morphology at later time points ([F] is at 1 mo and
[G] 10 mo).
(H and I) The scar tissue is compartmentalized with patches of ependyma-derived cells.
(J and K) Electron micrographs of b-gal–immunoreactive cells with astrocyte (J) or oligodendrocyte (K) morphology. Boxed areas are shown at a higher
magnification in the insets.
(L) Drawing (based on [C]) depicting the distribution of recombined cells of different phenotypes.
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Spinal Cord Neural Stem Cellscells as well as their progeny were, however, negative for
CXCR4 (Figure S9), making it unlikely that this receptor
mediates the attraction of ependymal cell progeny to a spinal
cord lesion.
Analysis of the fate of the ependymal cell progeny by
molecular markers and electron microscopy after a dorsal
funiculus incision revealed that the majority were immunor-
eactive to Sox9 and vimentin and had an astrocyte-like
morphology (Figures 6E, 6H, 6J, 6M, and S10). A smaller
subpopulation of the recombined cells expressed GFAP and
nestin, but the vast majority of cells with this phenotype were
not recombined (Figure 6D, 6H, 6I, and 6M). Recombined
GFAP- and nestin-expressing cells were typically located close
to the surface of the spinal cord (Figure 6D, 6H, 6I, and 6L),
whereas the Sox9- and vimentin-expressing cells were most
abundantinthecoreofthescartissue(Figures6LandS10).We
conclude that the glial scar is comprised of two different
populations of astrocyte-like cells, where the majority of the
Sox9
þ/vimentin
þpopulation derives from ependymal cells and
theGFAP
þ/nestin
þcellsaremainlyreactiveresidentastrocytes.
We further investigated the contribution of ependymal
cells to other lineages. None of the recombined cells in the
scar tissue had neuronal morphology or were immunoreac-
tive to the neuron-speciﬁc epitope NeuN (unpublished data).
A population of recombined cells expressed Olig2 (Figure 6F
and 6G). The ﬁrst month after injury, Olig2-expressing
recombined cells were scattered throughout the injury site
and had an ultrastructural morphology corresponding to
immature oligodendrocytes (Figure 6F, 6K, 6L, and 6M). At
later time points, Olig2-expressing ependyma-derived cells
were excluded from the scar tissue and were restricted to the
uninjured tissue that bordered the scar (Figure 6G, 6L, and
6M). Lesions in the lateral funiculus resulted in the
generation of ependymal progeny of the same fates as after
a dorsal funiculus incision (Figure S8).
Relationship between Ependymal Cell Progeny,
Extracellular Matrix Molecules, and Axons in Spinal Cord
Scar Tissue
The scar tissue that forms at spinal cord injuries is thought
to inhibit axonal growth [33,34]. Chondroitin sulphate
proteoglycans (CSPG) appear to be the principal axonal
growth inhibiting molecules in glial scars [35]. Ependyma-
derived cells at the injury formed a complementary non-
overlapping pattern with areas that were CSPG immunor-
eactive (Figure 7A and 7B), indicating that ependymal cell
progeny do not contribute to the production of axonal
growth-inhibiting CSPG.
In parallel with the production of axonal growth-inhibiting
factors in the glial scar, there is an increase in some axonal
growth-promoting molecules, such as the extracellular matrix
molecules laminin and ﬁbronectin [36,37]. In the injury
model employed here, axons send sprouts into the scar tissue,
mainly during the ﬁrst month after an injury, and the axons
are preferentially associated with areas in the scar tissue that
have high levels of laminin [38,39]. Both laminin and
ﬁbronectin immunoreactivity were widely distributed
throughout the scar tissue, overlapping both with CSPG-
immunoreactive domains and areas occupied by ependyma-
derived cells (Figure 7A and 7B). Neuroﬁlament-immunor-
eactive axons were present in the center of the scar tissue and
were often wiggly and oriented in all directions (Figure 7C–
7H). This is in contrast to the rostrocaudal orientation of
axons seen in the uninjured dorsal funiculus, suggesting that
many of the axons present in the scar were severed and
sprouting into the scar tissue [39]. Neuroﬁlament-immunor-
eactive axons were present in domains dominated by
ependyma-derived cells, as well as in other areas of the scar
where these cells were less abundant (Figure 7C–7H). Axons
were often present in direct proximity to ependyma-derived
cells (Figure 7D, 7E, 7G, and 7H). The ﬁnding that ependyma-
derived progeny is not associated with the main scar-
associated axonal growth-inhibiting factor, CSPG, together
with their proximity to axonal sprouts, argues against these
cells being a major factor in glial scar-associated axonal
growth inhibition.
Ependymal Cells Generate Oligodendrocytes after Injury
The ﬁnding that some ependymal cell progeny displayed a
marker proﬁle and ultrastructural morphology suggesting
oligodendroglial differentiation (Figure 6) prompted us to
characterize these cells further and to address whether they
may contribute to axonal remyelination at later time points.
Ten months after spinal cord injury, the majority of
ependyma-derived progeny are located in the scar tissue that
has formed at the injury site, but a substantial number of cells
are sparsely distributed in a large area of the intact grey and
white matter bordering the lesion (Figure 8A–8C). Most of
these cells are Olig2
þ and display mature oligodendrocyte
morphology with processes that extend along and enwrap
myelin basic protein (MBP)-immunoreactive myelin en-
sheathing axons (Figure 8B–8D).
Nuclear regions and processes of two ependyma-derived
cells were followed in the electron microscope in serial
utrathin sections (Figures 9 and S11, and unpublished data).
They both displayed a typical mature oligodendrocyte
morphology [25], such as oval nuclei with clumped chromatin,
a cytoplasmic matrix that appeared denser than in surround-
ing astrocytes, a granular endoplasmic reticulum represented
by several short cysternae, and tight junctions with adjacent
oligodendrocyte processes (Figure 9). Few processes emerged
from the cell body, and unlike those of astrocytes, they did
not form many branches and did not contain evident ﬁbrils
(Figure 9). The processes of the recombined cells could be
traced along axons, surrounding their myelin sheaths (Figure
9D). Thus, in addition to the generation of astrocytes,
ependymal cells generate myelinating oligodendrocytes.
Discussion
Stem cells are notoriously difﬁcult to identify, and their
localization in the adult spinal cord has been controversial
[6–9]. We report that ependymal cells constitute the vast
(M) Marker profile of recombined ependyma-derived cells (mean and SD from 3 mice at each time point) in the area encompassing the injury indicated
by hatched lines in (L).
c, caveolae; f, filaments; ld, lipid droplet; n, nucleus.
Scale bars indicate 25 lm in (D–G) and (H), 50 lm in (I), 2 lm in (J), 1 lm in (K), and 0.15 lm in insets in (J) and (K).
doi:10.1371/journal.pbio.0060182.g006
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Spinal Cord Neural Stem CellsFigure 7. Relationship between Ependymal Cell-Derived Progeny, Axonal Growth-Modulating Molecules, and Axons in the Scar Tissue
(A–E) Chondroitin sulphate proteoglycans (CSPG), which are axonal growth inhibitory, are abundant in the scar tissue 2 wk after a dorsal funiculus
lesion. CSPG are present in a complementary and nonoverlapping pattern to b-gal–expressing ependyma-derived cells. The extracellular matrix proteins
fibronectin (A) and laminin (B and F), which are permissive to axonal sprouting, are widely distributed within the scar tissue and overlap with b-gal–
expressing ependyma-derived cells. (C–H) Neurofilament (NF)-immunoreactive axons in the scar tissue are rarely present in CSPG
þ areas (C–E) but are
associated with ependymal cell progeny (C–H) and laminin (F–H) in the core of the forming scar tissue 2 wk after injury. Scale bars indicate 100 lm.
doi:10.1371/journal.pbio.0060182.g007
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Spinal Cord Neural Stem Cellsmajority of cells displaying in vitro neural stem cell proper-
ties in the adult spinal cord. Ependymal cells self-renew in
vivo, but do not generate appreciable numbers of other cell
types under homeostatic conditions. Their normally limited
proliferation increases dramatically after spinal cord injury
and they then produce oligodendrocytes, and more abun-
dantly, astrocytes that migrate to the site of injury and make a
substantial part of the glial scar.
The immediate descendants of tissue stem cells, progenitor
cells with limited self-renewal capacity and/or lineage
potential, can in some situations acquire stem cell properties
[40]. For example, spermatogonial progenitor cells can regain
stem cell function after injury and during aging and forebrain
neurospheres may be derived from committed progenitors
[41,42]. It appears unlikely that this would explain the neural
stem cell properties displayed by ependymal cells in vitro, as
they are not replenished by any other cell type in the adult,
but are self-renewing. However, although ependymal cells at
the population level display cardinal stem cell features in
vivo, such as self-renewal and generation of diverse progeny,
it is difﬁcult to study these properties at the single cell level in
the tissue, and we cannot conclude that they act as stem cells
in vivo.
In addition to ependymal cells, neural progenitors (ex-
pressing NG2, Olig2, and/or Nkx2.2) reside in the white and
gray matter of the adult rodent spinal cord [6,43–46].
Different studies have suggested that the parenchymal
progenitors represent multipotent neural stem cells or
more-restricted glial progenitors [6,43,47]. Under the stand-
ard neurosphere assay conditions employed here, the vast
majority of the neural stem cell potential resides within the
ependymal population. However, we cannot exclude that
other cells contribute, to a comparatively smaller degree, to
neurosphere formation under our conditions or that they
may display neural stem cell properties under other
conditions. The parenchymal progenitors are likely to serve
to replace glial cells in the uninjured spinal cord, which we do
not ﬁnd evidence that ependymal cells do. Parenchymal
progenitors are rapidly depleted after spinal cord injury, but
are later replaced and may participate in the generation of
glial cells after injury [6,44,46]. It is possible that some of the
ependyma-derived Olig2
þ cells observed shortly after injury
represent regenerated parenchymal progenitors.
The limited functional recovery typically associated with
central nervous system injuries is in part due to the failure of
severed axons to regrow and reinnervate their targets. Axonal
Figure 8. Ependymal Cells Give Rise to Oligodendrocytes after Injury
(A) Ependymal cell-derived progeny are most abundant within the core of the scar tissue forming at the injury (arrow). Ependyma-derived cells are also
found, more sparsely, over a larger area in the intact tissue bordering the lesion (arrowheads), where they are associated with myelin basic protein
(MBP)-immunoreactive myelin ensheathing neurofilament (NF)-immunoreactive axons.
(B–D) Ependymal cell-derived progeny harboring an oligodendrocytic morphology are found both in the grey (B) and white matter (C), and some
recombined processes wrap around myelinated axon (D).
Scale bars indicate 100 lm in (A), 25 lm in (B) and (C), and 10 lm in (D).
doi:10.1371/journal.pbio.0060182.g008
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Spinal Cord Neural Stem Cellsregeneration is inhibited by scar formation and growth-
inhibitory factors associated with myelin and astrocytes
[48,49]. Modulating the responsiveness to axonal growth-
inhibitory factors and glial scar formation are attractive
strategies to improve functional recovery after central
nervous system injuries [50–53]. The majority of ependyma-
derived cells differentiate to astrocyte-like cells after injury
and are found in the core of the scar tissue. However, these
cells are found in complementary nonoverlapping domains
to areas immunoreactive to CSPG, the most important axonal
growth inhibitor associated with glial scars [35,36]. Moreover,
axons in the scar tissue, most likely sprouts from severed
axons growing into the scar tissue, were frequently found in
direct proximity to ependyma-derived cells. This argues that
ependyma-derived cells in the scar tissue do not constitute a
major impediment to axonal growth, and may even suggest
that they support some local sprouting.
Spinal cord injury results in the loss of oligodendrocytes
and demyelination of axons even at some distance to the
lesion [54,55]. Spinal cord injuries are most commonly
incomplete in man, leaving spared tissue connecting the
spinal cord above and below the lesion, but the function of
remaining axons is often compromised due to demyelination.
Without insulating sheaths of myelin, spared axons close to,
but not directly affected by the injury, become less efﬁcient in
their ability to conduct electrical impulses [56]. Moreover,
chronically demyelinated axons are vulnerable to degener-
ation. Axons are remyelinated with time, and this is thought
to occur through the generation of new oligodendrocytes by
stem or progenitor cells rather than by self-duplication of
mature remaining oligodendrocytes [57–59]. We report here
that ependymal cells contribute to the regeneration of
oligodendrocytes and remyelination after spinal cord injury.
The differentiation pattern of ependymal cells after injury is
reminiscent to that seen for in vitro expanded adult spinal
cord neural stem cells transplanted to the injured spinal cord
[5]. Transplanted adult spinal cord-derived neurospheres
improve functional recovery, and if they are forced to
generate more oligodendrocytes, functional recovery is
further improved [5]. Since ependymal cells are the main
source of neurospheres from the adult spinal cord (Figure 3),
promoting oligodendrocyte generation from these cells in
vivo could potentially improve recovery after spinal cord
injury. The development of pharmacological strategies to
modulate endogenous stem cells and their progeny may be an
attractive alternative to cell transplantation for the treatment
of spinal cord injury.
Materials and Methods
Generation of transgenic mice. For Nestin-CreER, we used the
enhancer found in the second intron of the rat nestin gene fused to a
minimal hsp68 promoter [18,60,61] that controls the expression of
CreER
T2 [62], as previously described [21]. For FoxJ1-CreER, we used a
human FOXJ1 promoter [13] fused to a CreER
T2 ires-EGFP construct.
Transgenic mice were generated at the Karolinska Center for
Transgene Technologies by standard procedures utilizing pronuclear
injection of CBA 3 C57BL/six fertilized eggs. Potential founder
animals were screened by Southern blot analysis and PCR analysis
using a CreER
T2-speciﬁc fragment as probe or PCR template.
Founder mice were bred to wild-type C57Bl/6 mice. Expression of
the transgene was analyzed by confocal microscopy of sections
stained with anti-Cre antibodies and cell-speciﬁc markers. Recombi-
nation was induced by ﬁve daily intraperitoneal injections of 2 mg of
tamoxifen (Sigma; 20 mg/ml in corn oil).
Immunohistochemistry. Adult mice were perfused transcardially
with PBS followed by 4% formaldehyde in PBS, spinal cords were
post-ﬁxed overnight at 4 8C and then cryoprotected in 30% sucrose.
Coronal (14 or 20 lm) or sagittal (20 lm, from ;9-mm-long pieces)
sections were collected alternating on ten slides (8–10 sections per
slide). Sections were incubated with blocking solution (10% donkey
serum in PBS, with 0.3% Triton-X100) for 1 h at room temperature,
then incubated at 4 8C or room temperature in a humidiﬁed chamber
for 12–48 h with primary antibodies diluted in blocking solution. For
MBP staining, sections were ﬁrst delipidized. For antibodies raised in
mouse, the M.O.M. kit (Vector), ABC kit (Vector), and TSA system
(Perkin Elmer) were used following the manufacturers’ instructions.
The following primary antibodies were used: b-galactosidase (1:5,000,
rabbit; ICN Biomedicals, or 1:1,000, goat; Biogenesis), BrdU, (1:200,
rat; Accurate), CD133 (1:500, rat, clone 13A4; eBioscience), chon-
droitin sulfate (1:1,000, mouse; Sigma), Cre (1:2,000, mouse; Nordic
BioSite), Crocc (1:5,000, rabbit, Root6; gift from T.Li), CXCR4 (1:500,
mouse; BD Pharmingen), ﬁbronectin (1:1,000, rabbit; Sigma), GFAP
(1:1,000, mouse, clone G-A-5; Sigma), Ki67 (1:1,000, rabbit; Neo-
markers), Olig2 (1:500, goat; R&D Systems), laminin (1:1,000, rabbit;
Sigma), MBP (1:500, rabbit; Chemicon), musashi-1 (1:2,000, rat, clone
14H1; gift from H.Okano), nestin (1:5,000, rabbit [63] or 1:500, mouse;
BD Pharmingen), neuroﬁlament heavy (1:1,000, chicken; Chemicon),
PDGFRa (1:500; BD Pharmingen), RC1 (1:200, mouse; DSHB), Sox2
(1:500, mouse; Chemicon, or 1:1,000, goat; gift from J. Muhr), Sox3
(1:500, rabbit; gift from T.Edlund), Sox9 (1:500, goat; R&D Systems),
vimentin (1:1,000, chicken; Chemicon). After washing, antibody
staining was revealed using species-speciﬁc ﬂuorophore-conjugated
(Cy3, Cy5 from Jackson, and Alexa 488 from Molecular Probes) or
biotin-conjugated secondary antibodies (Jackson). Biotinylated sec-
ondary antibodies were revealed using the ABC kit (Vector Labs) with
TSA ﬂuorescent ampliﬁcation kit (Perkin-Elmer). Sections were
counterstained with DAPI (1 lg/ml; Sigma). Control sections were
stained with secondary antibody alone. Pictures were taken using a
Zeiss Axioplan 2, Zeiss Axiovert 200M or a LSM510 META confocal
microscope with Zeiss and Openlab (Improvision) software. Image
processing and assembly was performed in ImageJ and Photoshop.
Figure 9. Ultrastructure of an Ependyma-Derived Oligodendrocyte
Electron micrograph of an ependyma-derived b-gal–expressing cell in
the nuclear plane 10 mo after injury (nucleus labeled with asterisk in [A]).
(A) The cell displays ultrastructural characteristics of a mature
oligodendrocyte such as a denser cytoplasm with fewer intermediate
filaments than that of a neighboring astrocyte (As), (B) tight junctions (tj)
between the cell body, and an oligodendrocyte process of another cell
and (C) granular endoplasmic reticulum (er) cycternae in the perikaryon.
Ax, axon; f, filamentous matrix.
(D) A process (p) of the cell adjacent to the myelin sheath on an axon.
Scale bars indicate 1 lm in (A) and 250 nm in (C) and (D).
doi:10.1371/journal.pbio.0060182.g009
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Spinal Cord Neural Stem CellsImmunoelectron microscopy. Anaesthetized mice were perfused
transcardially with 4% paraformaldehyde in PBS. The spinal cord was
dissected out and post-ﬁxed for 4 h. Sections (60 lm) were
immunolabled with Cre or b-gal antibodies in 0.1% Triton X100
and 10% donkey serum in PBS. A secondary antibody conjugated to
biotin was used with an ABC kit (Vector Labs). In some sections, a
ﬂuorescent secondary antibody was used, and sections were labeled
with DAPI to map the location of the nuclei of the surrounding cells
(Figure S11). The sections were post-ﬁxed in 3% glutaraldehyde in 0.1
M cacodylate buffer (pH 7.4) and in 1% osmium tetraoxide in 0.1 M
cacodylate buffer, dehydrated in a graded series of ethanol, stained
with uranyl acetate, and embedded in Durcupan resin (Fluka). Serial
sections (200 nm) of FoxJ1-CreER spinal cord were used to deﬁne the
ultrastructural morphology of cells lining the central canal. The
complete series of sections from individual cells were traced in 90
sections to characterize the morphology in three dimensions. Serial
semi- and ultrathin sections (2 lm and 70 nm, respectively) were used
in correlative light and electron microscopic evaluation (CLEM) of the
fate of ependyma-derived cells 4 wk after a spinal cord injury (Figure
S6). The semithin sections were used to identify immunopositive cells,
and the ultrathin sections to show the morphology of the identiﬁed
cells. Sections (70–200 nm) were placed on Formvar-coated copper
grids, counterstained with 2% uranyl acetate and Reynold’s lead
citrate. Sections were examined in a Tecnai 12 electron microscope
(FEI) equipped with 2kx2k TemCam-F224HD camera (TVIPS).
Neural stem cell cultures. Spinal cords were dissected and cells
dissociated using papain (Worthington). Neurospheres were cultured
as described [8] in DMEM/F12 medium supplemented with B27 and
EGF and bFGF (both 10 ng/ml). Approximately 200,000 cells were
plated in 10-cm cultures dishes, corresponding to a density of 20 cells/
microliter, which allows the generation of clonal neurospheres [64].
For assaying self-renewal and multipotentiality, FoxJ1-CreERxR26R (n
¼6) and Nestin-CreERxR26R (n¼6) adult mice were administered with
tamoxifen intraperitoneally for 5 d with a washout period of 6 d (see
Figure 3). Single spheres were manually collected and split into two
wells. One well was used for continuous passaging and subsequent
neural stem cell differentiation, whereas the other well was used for
X-gal staining. For assaying self-renewal, four clonal recombined
neurospheres per animal were manually isolated after 12 d of primary
neurosphere formation. All recombined neurospheres were serially
passaged eight times. In vitro differentiation by growth factor
withdrawal for 10 d was assessed in passage 3 and passage 6 by
staining as described above for bIII-tubulin (Tuj1, 1:1,000; Covance),
GFAP (1:5,000; DAKO), and O4 (1:200; Chemicon).
Flow cytometry. Spinal cords were dissected from FoxJ1-CreER
mice and dissociated using papain (Worthington) and DNase in 13
HBSS at 37 8C for 1 h. Ovomucoid inhibitor (Worthington) was added
and cells were collected by centrifugation at 300g for 5 min. Cells
were resuspended in Leibovitz-15/B27 with 7AAD, which labels dead
cells. Single GFP
þ (based on the ires-GFP signal), 7AAD
  cells were
isolated using a FACSAria (BD). Singlets were identiﬁed based on
forward scatter width (FSC-W) versus forward scatter height (FCS-H)
[65]. Single cell sorting and GFP ﬂuorescence was conﬁrmed by
microscopic examination.
Spinal cord injury, BrdU, and growth factor treatments. Mice were
anesthetized with 2.5% Avertin, and the dorsal funiculus at mid-
thoracic level was cut transversely and was extended rostrally with
microsurgical scissors to span one segment [39]. In other animals, the
lateral funiculus was cut transversally and the lesion extended
rostrally to span one segment.
BrdU (1 mg/ml and 1% sucrose, exchanged every 3–4 d) was
administered in the drinking water to label dividing cells.
Quantitative analyses. In order to correlate recombination
frequency in neurosphere cultures to the in vivo recombination
frequency of spinal cord tissue, the ratio between CreER
þ and b-gal
þ
cells (n¼60) was quantiﬁed in a small postﬁxed biopsy from the same
spinal cords used for neurosphere cultures.
The percentage of BrdU
þependymal cells was obtained from three
animals treated for 4 wk with BrdU in the drinking water (3–5
coronal sections/animal analyzed). The total number of cells per
section was obtained counting all nuclei stained with DAPI.
The in vivo recombination frequency was assessed by counting the
number of recombined cells over the total number of ependymal cells
(Vimentin
þ) from ﬁve coronal sections per animals at 2 d (4 animals: 2
Nestin-CreERxR26R,2FoxJ1-CreERxR26R) and 10 mo (3 animals: 3
FoxJ1-CreERxR26R) after tamoxifen treatment (Figure 4E).
The contribution of recombined cells at the site of injury was
established by measuring the relative area occupied by b-gal
þ cells
within the epicenter of the lesion (using ImageJ software) of 3 FoxJ1-
CreERxR26R animals (2 sagittal sections per animal) 2 wk after spinal
cord injury.
The cell fate distribution of ependyma-derived progeny was
obtained by scoring recombined cells positive for Olig2, GFAP or
Sox9 in either coronal (3–5 sections per animal) or sagittal (1–2
sections per animal) sections encompassing the lesion site from 1
month (3 animals: 1 Nestin-CreERxZ/EG,2FoxJ1-CreERxR26R) and 8–
10 mo (4 animals: 1 Nestin-CreERxZ/EG and 3 FoxJ1-CreERxR26R) after
spinal cord injury (Figure 6M).
The frequency of proliferation of ependymal cells and their
progeny was assessed by counting the number of Ki67
þ recombined
cells over the total number of recombined cells from three segments
(rostral to, caudal to, and at the injury site; average of 15 coronal
sections, or 300 recombined cells, per segment analyzed) from 2
FoxJ1-CreERxR26R animals 4 d after spinal cord injury (Figure S7C).
Supporting Information
Figure S1. Schematic Illustration of Transgenic Constructs and
Genetic Labeling Strategy
(A) The Nestin 2nd intron central nervous system (CNS)-speciﬁc stem/
progenitor enhancer (NestinE) with a minimal hsp68 promoter drives
CreER expression. The human FoxJ1 promoter drives CreER and
EGFP expression in ependymal cells with motile cilia. CreER protein
is cytoplasmic due to the association with the heat-shock chaperone
complex.
(B) Nuclear localization of CreER and recombination is induced upon
4-hydroxytamoxifen (4-OHT) binding to the ER domain. The
reporter allele consists of a loxP-ﬂanked transcriptional stop cassette.
Cre recombination induces the expression of the reporter protein (b-
gal or GFP) under a general and ubiquitous promoter.
Found at doi:10.1371/journal.pbio.0060182.sg001 (205 KB TIF).
Figure S2. Molecular Marker Expression by Adult Spinal Cord
Ependymal Cells
(A–D) Ciliary rootlet coiled-coil protein (Crocc, also known as
Rootletin) is expressed in Sox2 (a neural stem cell marker) positive
ciliated ependymal cells of the adult spinal cord and colocalizes with
b-gal expression in recombined ependymal cells.
(E–H) Ependymal cells are immunoreactive to the neural stem cell-
associated protein CD133/Prominin, which is localized at the luminal
surface (shown in higher magniﬁcation in [H]).
(I–L) Nestin, but not GFAP, is expressed in recombined b-gal
þ
ependymal cells.
(M–P) The RC1 antigen associated with radial glial cells is expressed
in ependymal cells and recombined ependymal cells express Sox9, an
immature glial marker. The analysis is from uninjured FoxJ1-
CreERxR26R mice 6 d after termination of tamoxifen administration.
The scale bar indicates 25 lm.
Found at doi:10.1371/journal.pbio.0060182.sg002 (5.51 MB TIF).
Figure S3. Molecular Marker Expression by Adult Spinal Cord
Ependymal Cells
(A–D) Musashi-1 (Msi1), (E–H) PDGFRa and vimentin, all associated
with neural stem/progenitor cells, are expressed in recombined
ependymal cells. Recombined ependymal cells also express the neural
stem cell-associated proteins Sox3 (I–L) and Sox2 (M–O), but not the
astrocyte marker GFAP (D) nor the oligodendrocyte progenitor
marker Olig2 (P). The analysis is from uninjured FoxJ1-CreERxR26R
mice 6 d after termination of tamoxifen administration. The scale bar
indicates 25 lm.
Found at doi:10.1371/journal.pbio.0060182.sg003 (6.78 MB TIF).
Figure S4. Correlative Light and Electron Microscopy (CLEM)
Analysis
(A) Schematic illustration showing the sequence of semithin and
ultrathin sections used to study the morphology of cells migrating
from the central canal in three dimensions. (B) An example of a b-
gal
þ cell identiﬁed at the light microscopic level following PAP
immunocytochemistry. The labeled cell is shown in an electron
micrograph from a neighboring, ultrathin section in (C). The scale
bar indicates 2 lm.
Found at doi:10.1371/journal.pbio.0060182.sg004 (3.37 MB TIF).
Figure S5. Morphological Features of Ependymal Cells
(A) An electron micrograph of ependymal cells (e) and tanycytes (t)
lining the central canal of the spinal cord. Arrows point to processes
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Spinal Cord Neural Stem Cellsextending from tanycytes. The inset shows a light micrograph of a
neighboring 2-lm semithin section where the PAP staining is evident.
Asterisks mark lipid droplets.
(B) An ependymal cell with a cilium (c) and multiple villi (v).
(C) An electron micrograph of a multiciliated tanycyte with a process.
Note that the tanycyte has a darker cytoplasm compared to
ependymal cells.
(D) A cross-section of a cilium with microtubules arranged in a 9 þ2
array. Only this type of cilium was found in ependymal cells,
tanycytes, and radial ependymal cells.
(E) The electron dense PAP reaction product signaling for Cre is
shown at high magniﬁcation.
(F) An example of an ependymal cell with two cilia. Arrows point to
the basal bodies.
(G) A tight junction (arrow) between an ependymal cell and a
tanycyte.
(H) An electron micrograph showing a Cre
þ radial ependymal cell (r)
with a process (arrow) and a lipid droplet (asterisk). The inset shows a
light micrograph of the PAP labeling.
(I) High magniﬁcation of the cytoplasm and villi of a radial
ependymal cell extending into the lumen of the central canal.
(J) An electron micrograph of the basal body and cilia of a radial
ependymal cell.
(A–J) are from FoxJ1-CreER mice.
(K) Electron micrograph of Cre-immunopositive ependymal cells,
radial ependymal cells, and tanycytes at the central canal of the spinal
cord from the Nestin-CreER mouse.
bv: blood vessel; m: mitochondrion; n: nucleus.
The scale bars indicate 5 lm in (A) and (K), 1 lm in (B), (E), (F), and (J),
2 lm in (C) and (H), 0.1 lm in (D) and (G), and 0.25 lm in (I).
Found at doi:10.1371/journal.pbio.0060182.sg005 (7.38 MB TIF).
Figure S6. Exponential Growth of Ependymal Cell-Derived Neuro-
sphere Cells In Vitro
The number of cells obtained after sequential clonal passaging,
starting with individual recombined primary neurospheres from
Nestin-CreER crossed with R26REYFP mice [66]. Each line represents
the mean 6 SD from four clones from one animal.
Found at doi:10.1371/journal.pbio.0060182.sg006 (124 KB TIF).
Figure S7. Spinal Cord Injury Induces Proliferation of Ependymal
Cells
(A and B) Proliferation and Ki67 expression are induced in
ependymal cells close to and in the injury (B), but not in adjacent
uninjured segments (A).
(C) Quantiﬁcation of the injury-induced proliferative response of
ependymal cells at different locations relative to the epicenter of the
injury.
(D–F) Representative image of the quantiﬁed area (D), with boxed
areas depicting the central canal region (E) and the migrating
ependyma-derived cells entering the lesion area (F).
Scale bars indicate 25 lm in (A), (B), (E), and (F), and 50 lm in (D).
Found at doi:10.1371/journal.pbio.0060182.sg007 (3.21 MB TIF).
Figure S8. Migration of Ependymal Cell Progeny to Lateral Spinal
Cord Lesions
(A–C) Distribution of b-gal–immunoreactive ependymal cells and
their progeny 2 wk after a laminectomy only (sham [A]) and a right (B)
or a left (C) lateral funiculus incision. GFAP immunoreactivity
demarcates the injury site (indicated by hatched lines).
Four weeks after a lateral injury, ependymal cells give rise to Sox9
þ
(D), GFAP
þ (E), and Olig2
þ (F) cells, as after a dorsal funiculus lesion.
Scale bars indicate 200 lm in (A–C) and 20 lm in (D–F).
Found at doi:10.1371/journal.pbio.0060182.sg008 (2.22 MB TIF).
Figure S9. Relationship between Ependymal Cells, Their Progeny, and
CXCR4 Immunoreactivity
(A–F) Most ependymal cells (identiﬁed by b-gal and vimentin in a
FoxJ1-CreERxR26R mouse) do not display detectable CXCR4-
immunoreactivty (yellow arrowheads), although some ependymal cell
processes appear CXCR4-immunoreactive (white arrowheads).
(G–I) Two weeks after a dorsal funiculus lesion, many cells in the
forming scar tissue are CXCR4 immunoreactive, but the b-gal–
expressing ependyma-derived cells appear negative for CXCR4.
Scale bars indicate 25 lm in (A–F) and 50 lm in (G–I).
Found at doi:10.1371/journal.pbio.0060182.sg009 (3.27 MB TIF).
Figure S10. Central Canal Ependymal Cells Are Not Depleted after
Injury and Maintain Their Phenotype over 8 Mo
(A and B) A sagittal section showing Sox9 and vimentin expression in
recombined ependymal cells of the central canal in an uninjured
segment 8 mo after spinal cord injury.
(C–E) In the injured segment of the same animal, ependyma-derived
recombined (b-gal
þ) cells occupying the scar tissue ([C] and higher
magniﬁcation in [D]) as well as ependymal cells at the central canal
([C] and higher magniﬁcation in [E]) are still Sox9
þ and Vim
þ 8m o
after injury.
Scale bars indicate 25 lm in (A) and (D) and 100 lm in (C) and (E).
Found at doi:10.1371/journal.pbio.0060182.sg010 (3.87 MB TIF).
Figure S11. Identiﬁcation of an Ependyma-Derived Cell at the
Ultrastructural Level
(A and B) The nuclei of an ependyma-derived b-gal–immunoreactive
cell and surrounding cells were labeled with DAPI. The b-gal–
immunoreactive cell was identiﬁed in the electron microscope by the
position of the nucleus in a 3D reconstruction of serial 120-nm-thick
sections of the whole area.
(C) The b-gal–immunoreactive cell is indicated by an asterisk and
surrounding cells are numbered. BV: blood vessel.
Scale bars indicate 10 lm.
Found at doi:10.1371/journal.pbio.0060182.sg011 (907 KB TIF).
Table S1. Morphological Characteristics of Ependymal Cells
Details for the studied cells lining the central canal of the spinal cord
by immunoelectron microscopy, which underlie classiﬁcation into
the cell types shown in Figure 1. Each cell shown in the table was
traced in complete series of ultrathin sections. Color coding
corresponds to the Venn diagram in Figure 1. Ependymal cells are
cyan, tanycytes are orange, and radial ependymal cells are purple.
Green represents an intermediate population of cells with a dark
cytoplasm, without any process. Black represents a second inter-
mediate population with a light cytoplasm, multiple cilia, and with a
process. Red represents a population of cells with an irregular
nucleus, light cytoplasm, a process, and only one cilium.
Found at doi:10.1371/journal.pbio.0060182.st001 (323 KB TIF).
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